Global Cell-free DNA Mutation Diagnostics Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Kits
1.2.3 Instruments
1.2.4 Services
1.3 Market by Application
1.3.1 Global Cell-free DNA Mutation Diagnostics Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hoispital
1.3.3 Clinic
1.3.4 Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-free DNA Mutation Diagnostics Market Perspective (2021–2032)
2.2 Global Cell-free DNA Mutation Diagnostics Growth Trends by Region
2.2.1 Global Cell-free DNA Mutation Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell-free DNA Mutation Diagnostics Historic Market Size by Region (2021–2026)
2.2.3 Cell-free DNA Mutation Diagnostics Forecasted Market Size by Region (2027–2032)
2.3 Cell-free DNA Mutation Diagnostics Market Dynamics
2.3.1 Cell-free DNA Mutation Diagnostics Industry Trends
2.3.2 Cell-free DNA Mutation Diagnostics Market Drivers
2.3.3 Cell-free DNA Mutation Diagnostics Market Challenges
2.3.4 Cell-free DNA Mutation Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-free DNA Mutation Diagnostics Players by Revenue
3.1.1 Global Top Cell-free DNA Mutation Diagnostics Players by Revenue (2021–2026)
3.1.2 Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell-free DNA Mutation Diagnostics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell-free DNA Mutation Diagnostics Revenue
3.4 Global Cell-free DNA Mutation Diagnostics Market Concentration Ratio
3.4.1 Global Cell-free DNA Mutation Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-free DNA Mutation Diagnostics Revenue in 2025
3.5 Global Key Players of Cell-free DNA Mutation Diagnostics Head Offices and Areas Served
3.6 Global Key Players of Cell-free DNA Mutation Diagnostics, Products and Applications
3.7 Global Key Players of Cell-free DNA Mutation Diagnostics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell-free DNA Mutation Diagnostics Breakdown Data by Type
4.1 Global Cell-free DNA Mutation Diagnostics Historic Market Size by Type (2021–2026)
4.2 Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Type (2027–2032)
5 Cell-free DNA Mutation Diagnostics Breakdown Data by Application
5.1 Global Cell-free DNA Mutation Diagnostics Historic Market Size by Application (2021–2026)
5.2 Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell-free DNA Mutation Diagnostics Market Size (2021–2032)
6.2 North America Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell-free DNA Mutation Diagnostics Market Size by Country (2021–2026)
6.4 North America Cell-free DNA Mutation Diagnostics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-free DNA Mutation Diagnostics Market Size (2021–2032)
7.2 Europe Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2021–2026)
7.4 Europe Cell-free DNA Mutation Diagnostics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size (2021–2032)
8.2 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell-free DNA Mutation Diagnostics Market Size (2021–2032)
9.2 Latin America Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell-free DNA Mutation Diagnostics Market Size by Country (2021–2026)
9.4 Latin America Cell-free DNA Mutation Diagnostics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size (2021–2032)
10.2 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Cell-free DNA Mutation Diagnostics Introduction
11.1.4 Illumina Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.1.5 Illumina Recent Development
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera Cell-free DNA Mutation Diagnostics Introduction
11.2.4 Natera Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.2.5 Natera Recent Development
11.3 Guardant
11.3.1 Guardant Company Details
11.3.2 Guardant Business Overview
11.3.3 Guardant Cell-free DNA Mutation Diagnostics Introduction
11.3.4 Guardant Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.3.5 Guardant Recent Development
11.4 Freenome Holdings
11.4.1 Freenome Holdings Company Details
11.4.2 Freenome Holdings Business Overview
11.4.3 Freenome Holdings Cell-free DNA Mutation Diagnostics Introduction
11.4.4 Freenome Holdings Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.4.5 Freenome Holdings Recent Development
11.5 GRAIL
11.5.1 GRAIL Company Details
11.5.2 GRAIL Business Overview
11.5.3 GRAIL Cell-free DNA Mutation Diagnostics Introduction
11.5.4 GRAIL Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.5.5 GRAIL Recent Development
11.6 Exact Sciences Corporation
11.6.1 Exact Sciences Corporation Company Details
11.6.2 Exact Sciences Corporation Business Overview
11.6.3 Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Introduction
11.6.4 Exact Sciences Corporation Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.6.5 Exact Sciences Corporation Recent Development
11.7 Foundation Medicine
11.7.1 Foundation Medicine Company Details
11.7.2 Foundation Medicine Business Overview
11.7.3 Foundation Medicine Cell-free DNA Mutation Diagnostics Introduction
11.7.4 Foundation Medicine Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.7.5 Foundation Medicine Recent Development
11.8 Biocept
11.8.1 Biocept Company Details
11.8.2 Biocept Business Overview
11.8.3 Biocept Cell-free DNA Mutation Diagnostics Introduction
11.8.4 Biocept Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.8.5 Biocept Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Introduction
11.9.4 Thermo Fisher Scientific Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Roche Diagnostics
11.10.1 Roche Diagnostics Company Details
11.10.2 Roche Diagnostics Business Overview
11.10.3 Roche Diagnostics Cell-free DNA Mutation Diagnostics Introduction
11.10.4 Roche Diagnostics Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.10.5 Roche Diagnostics Recent Development
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Details
11.11.2 Agilent Technologies Business Overview
11.11.3 Agilent Technologies Cell-free DNA Mutation Diagnostics Introduction
11.11.4 Agilent Technologies Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.11.5 Agilent Technologies Recent Development
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Details
11.12.2 Quest Diagnostics Incorporated Business Overview
11.12.3 Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Introduction
11.12.4 Quest Diagnostics Incorporated Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.12.5 Quest Diagnostics Incorporated Recent Development
11.13 Laboratory Corporation of America Holdings
11.13.1 Laboratory Corporation of America Holdings Company Details
11.13.2 Laboratory Corporation of America Holdings Business Overview
11.13.3 Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Introduction
11.13.4 Laboratory Corporation of America Holdings Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.13.5 Laboratory Corporation of America Holdings Recent Development
11.14 Myriad Genetics
11.14.1 Myriad Genetics Company Details
11.14.2 Myriad Genetics Business Overview
11.14.3 Myriad Genetics Cell-free DNA Mutation Diagnostics Introduction
11.14.4 Myriad Genetics Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.14.5 Myriad Genetics Recent Development
11.15 BillionToOne
11.15.1 BillionToOne Company Details
11.15.2 BillionToOne Business Overview
11.15.3 BillionToOne Cell-free DNA Mutation Diagnostics Introduction
11.15.4 BillionToOne Revenue in Cell-free DNA Mutation Diagnostics Business (2021–2026)
11.15.5 BillionToOne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Kits
Table 3. Key Players of Instruments
Table 4. Key Players of Services
Table 5. Global Cell-free DNA Mutation Diagnostics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Cell-free DNA Mutation Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Cell-free DNA Mutation Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 8. Global Cell-free DNA Mutation Diagnostics Market Share by Region (2021–2026)
Table 9. Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Cell-free DNA Mutation Diagnostics Market Share by Region (2027–2032)
Table 11. Cell-free DNA Mutation Diagnostics Market Trends
Table 12. Cell-free DNA Mutation Diagnostics Market Drivers
Table 13. Cell-free DNA Mutation Diagnostics Market Challenges
Table 14. Cell-free DNA Mutation Diagnostics Market Restraints
Table 15. Global Cell-free DNA Mutation Diagnostics Revenue by Players (US$ Million), 2021–2026
Table 16. Global Cell-free DNA Mutation Diagnostics Market Share by Players (2021–2026)
Table 17. Global Top Cell-free DNA Mutation Diagnostics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell-free DNA Mutation Diagnostics Revenue, 2025
Table 18. Ranking of Global Top Cell-free DNA Mutation Diagnostics Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Cell-free DNA Mutation Diagnostics Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Cell-free DNA Mutation Diagnostics, Headquarters and Area Served
Table 21. Global Key Players of Cell-free DNA Mutation Diagnostics, Products and Applications
Table 22. Global Key Players of Cell-free DNA Mutation Diagnostics, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Cell-free DNA Mutation Diagnostics Market Size by Type (US$ Million), 2021–2026
Table 25. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Type (2021–2026)
Table 26. Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Type (2027–2032)
Table 28. Global Cell-free DNA Mutation Diagnostics Market Size by Application (US$ Million), 2021–2026
Table 29. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Application (2021–2026)
Table 30. Global Cell-free DNA Mutation Diagnostics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Cell-free DNA Mutation Diagnostics Revenue Market Share by Application (2027–2032)
Table 32. North America Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Cell-free DNA Mutation Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 34. North America Cell-free DNA Mutation Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Cell-free DNA Mutation Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Cell-free DNA Mutation Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Cell-free DNA Mutation Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Cell-free DNA Mutation Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size by Country (US$ Million), 2027–2032
Table 47. Illumina Company Details
Table 48. Illumina Business Overview
Table 49. Illumina Cell-free DNA Mutation Diagnostics Product
Table 50. Illumina Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 51. Illumina Recent Development
Table 52. Natera Company Details
Table 53. Natera Business Overview
Table 54. Natera Cell-free DNA Mutation Diagnostics Product
Table 55. Natera Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 56. Natera Recent Development
Table 57. Guardant Company Details
Table 58. Guardant Business Overview
Table 59. Guardant Cell-free DNA Mutation Diagnostics Product
Table 60. Guardant Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 61. Guardant Recent Development
Table 62. Freenome Holdings Company Details
Table 63. Freenome Holdings Business Overview
Table 64. Freenome Holdings Cell-free DNA Mutation Diagnostics Product
Table 65. Freenome Holdings Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 66. Freenome Holdings Recent Development
Table 67. GRAIL Company Details
Table 68. GRAIL Business Overview
Table 69. GRAIL Cell-free DNA Mutation Diagnostics Product
Table 70. GRAIL Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 71. GRAIL Recent Development
Table 72. Exact Sciences Corporation Company Details
Table 73. Exact Sciences Corporation Business Overview
Table 74. Exact Sciences Corporation Cell-free DNA Mutation Diagnostics Product
Table 75. Exact Sciences Corporation Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 76. Exact Sciences Corporation Recent Development
Table 77. Foundation Medicine Company Details
Table 78. Foundation Medicine Business Overview
Table 79. Foundation Medicine Cell-free DNA Mutation Diagnostics Product
Table 80. Foundation Medicine Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 81. Foundation Medicine Recent Development
Table 82. Biocept Company Details
Table 83. Biocept Business Overview
Table 84. Biocept Cell-free DNA Mutation Diagnostics Product
Table 85. Biocept Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 86. Biocept Recent Development
Table 87. Thermo Fisher Scientific Company Details
Table 88. Thermo Fisher Scientific Business Overview
Table 89. Thermo Fisher Scientific Cell-free DNA Mutation Diagnostics Product
Table 90. Thermo Fisher Scientific Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 91. Thermo Fisher Scientific Recent Development
Table 92. Roche Diagnostics Company Details
Table 93. Roche Diagnostics Business Overview
Table 94. Roche Diagnostics Cell-free DNA Mutation Diagnostics Product
Table 95. Roche Diagnostics Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 96. Roche Diagnostics Recent Development
Table 97. Agilent Technologies Company Details
Table 98. Agilent Technologies Business Overview
Table 99. Agilent Technologies Cell-free DNA Mutation Diagnostics Product
Table 100. Agilent Technologies Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 101. Agilent Technologies Recent Development
Table 102. Quest Diagnostics Incorporated Company Details
Table 103. Quest Diagnostics Incorporated Business Overview
Table 104. Quest Diagnostics Incorporated Cell-free DNA Mutation Diagnostics Product
Table 105. Quest Diagnostics Incorporated Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 106. Quest Diagnostics Incorporated Recent Development
Table 107. Laboratory Corporation of America Holdings Company Details
Table 108. Laboratory Corporation of America Holdings Business Overview
Table 109. Laboratory Corporation of America Holdings Cell-free DNA Mutation Diagnostics Product
Table 110. Laboratory Corporation of America Holdings Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 111. Laboratory Corporation of America Holdings Recent Development
Table 112. Myriad Genetics Company Details
Table 113. Myriad Genetics Business Overview
Table 114. Myriad Genetics Cell-free DNA Mutation Diagnostics Product
Table 115. Myriad Genetics Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 116. Myriad Genetics Recent Development
Table 117. BillionToOne Company Details
Table 118. BillionToOne Business Overview
Table 119. BillionToOne Cell-free DNA Mutation Diagnostics Product
Table 120. BillionToOne Revenue in Cell-free DNA Mutation Diagnostics Business (US$ Million), 2021–2026
Table 121. BillionToOne Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report


List of Figures
Figure 1. Cell-free DNA Mutation Diagnostics Picture
Figure 2. Global Cell-free DNA Mutation Diagnostics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cell-free DNA Mutation Diagnostics Market Share by Type: 2025 vs 2032
Figure 4. Kits Features
Figure 5. Instruments Features
Figure 6. Services Features
Figure 7. Global Cell-free DNA Mutation Diagnostics Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Cell-free DNA Mutation Diagnostics Market Share by Application: 2025 vs 2032
Figure 9. Hoispital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Cell-free DNA Mutation Diagnostics Report Years Considered
Figure 14. Global Cell-free DNA Mutation Diagnostics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Cell-free DNA Mutation Diagnostics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Cell-free DNA Mutation Diagnostics Market Share by Region: 2025 vs 2032
Figure 17. Global Cell-free DNA Mutation Diagnostics Market Share by Players in 2025
Figure 18. Global Cell-free DNA Mutation Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Cell-free DNA Mutation Diagnostics Revenue in 2025
Figure 20. North America Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Cell-free DNA Mutation Diagnostics Market Share by Country (2021–2032)
Figure 22. United States Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Cell-free DNA Mutation Diagnostics Market Share by Country (2021–2032)
Figure 26. Germany Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Cell-free DNA Mutation Diagnostics Market Share by Region (2021–2032)
Figure 34. China Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Cell-free DNA Mutation Diagnostics Market Share by Country (2021–2032)
Figure 42. Mexico Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Cell-free DNA Mutation Diagnostics Market Share by Country (2021–2032)
Figure 46. Israel Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Cell-free DNA Mutation Diagnostics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Illumina Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 50. Natera Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 51. Guardant Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 52. Freenome Holdings Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 53. GRAIL Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 54. Exact Sciences Corporation Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 55. Foundation Medicine Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 56. Biocept Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 58. Roche Diagnostics Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 59. Agilent Technologies Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 60. Quest Diagnostics Incorporated Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 61. Laboratory Corporation of America Holdings Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 62. Myriad Genetics Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 63. BillionToOne Revenue Growth Rate in Cell-free DNA Mutation Diagnostics Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit